Market revenue in 2023 | USD 37.2 million |
Market revenue in 2030 | USD 47.0 million |
Growth rate | 3.4% (CAGR from 2023 to 2030) |
Largest segment | Carbohydrates |
Fastest growing segment | Carbohydrates |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Carbohydrates, Proteins, Polymers, Minerals, Glycoside & Waxes, Esters, Ethers & Carboxylic Acids, Other Chemical Natures |
Key market players worldwide | Basf SE, Lonza Group Ltd, Evonik Industries AG, Roquette America, JRS Pharma, Micro Powders, Fumeipharm, Cristalco |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to plant-based excipients market will help companies and investors design strategic landscapes.
Carbohydrates was the largest segment with a revenue share of 21.24% in 2023. Horizon Databook has segmented the Spain plant-based excipients market based on carbohydrates, proteins, polymers, minerals, glycoside & waxes, esters, ethers & carboxylic acids, other chemical natures covering the revenue growth of each sub-segment from 2018 to 2030.
Spain has a high incidence of cancer; this is primarily due to the rapidly aging population. The Spanish Statistics Institute states that over 47 million people living in Spain are above the age of 65. The International Agency for Research on Cancer states that there were 282,000 cases of cancer in 2020, and by 2030, the incidence is expected to grow to 330,000.
Thus, the Spanish Ministry of Health, along with 10 other countries, signed the Valletta Declaration to jointly negotiate the price of expensive drugs, including advanced cancer drugs. These factors are expected to improve the demand for excipients, especially for cancer drugs, thus creating opportunities for market growth.
These factors are expected to boost the demand for plant-based excipients in the country. The pharmaceutical industry in Spain is one of the top 20 worldwide. High percentage of pensionable individuals in the country suggests a high likelihood of chronic and long-term treatment.
Horizon Databook provides a detailed overview of country-level data and insights on the Spain plant-based excipients market , including forecasts for subscribers. This country databook contains high-level insights into Spain plant-based excipients market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account